港股異動 | 維他奶國際反彈逾5% 獲兩家機構上調目標價
格隆匯11月24日丨昨日大跌超9%的維他奶國際(0345.HK)反彈5.49%,現報13.44港元,總市值144億港元。里昂將維他奶國際評級由“跑輸大市”升至“跑贏大市”,預計2023-25財年收入將同比增3%/10%/7%,目標價由15港元升至16.2港元。麥格理亦維持公司“跑贏大市”評級,目標價升至17.8港元。該行相信,集團中國內地營運情況已變得更為健康,在下半財年基數較低、價格上漲以及產能使用率持續上升,應可繼續推動利潤改善。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.